PHARMACEUTICALLY EFFECTIVE GINSENOSIDES AND THEIR USE

摘要

The invention provides use of panaxadiol for the treatment of conditions requiring stimulation of angiogenesis but not stimulation of chemoinvasion and use of panaxadiol in the manufacture of medicaments for treatment selected from the group consisting of promotion of late stage angiogenesis, maintenance of established neo-vasculature, treatment of myocardial ischaemia, treatment of diabetic nephropathy, healing of diabetic ulcers or pressure ulcers, treatment of cerebrovascular ischaemia and angina, increase of graft or implant survival, promotion of bone growth, healing of fractures, and preventing hair loss by promoting or maintaining an existing angiogenic response. A preferred panaxadiol is the naturally occuring ginsenoside Rb1.